Form 4: Liquidia Director Sells Shares After Option Exercise

Liquidia Corp. Director Raman Singh exercised stock options and subsequently sold 20,000 shares of common stock for a significant gain under a Rule 10b5-1 plan.

Summary

• Raman Singh, a Director of Liquidia Corp (LQDA), reported transactions on March 13, 2026.
• Singh exercised non-qualified stock options to acquire 20,000 shares of common stock at an exercise price of $4.86 per share.
• Immediately following the option exercise, Singh sold 20,000 shares of common stock at a volume-weighted average price of $36.0414 per share, with prices ranging from $36.01 to $36.20.
• The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following these transactions, Singh's direct beneficial ownership of common stock is 38,755 shares.
• The reported beneficial ownership includes 18,396 restricted stock units granted on June 17, 2025, which have not yet vested.
• An administrative error in a previous Form 4 filed on September 5, 2025, was corrected, which had inadvertently omitted the prior exercise of stock options for 7,500 shares, though the sale of those shares was disclosed.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While a director selling shares reduces insider ownership, the transaction was pre-planned under a 10b5-1 plan and represents a routine compensation-related liquidity event for the individual, not necessarily a negative signal for the company's prospects.

Positives

• Director Raman Singh realized a substantial gain by exercising options at $4.86 and selling shares at an average price of $36.0414.
• The transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a reaction to recent company performance.

Negatives

• Director Raman Singh reduced his direct beneficial ownership of common stock by 20,000 shares through the sale.

Risks

• No specific risks related to the company's operations or financial health are mentioned in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported in a Form 4, are routine disclosures for publicly traded companies. While a director's sale of shares can sometimes be interpreted negatively, the execution under a Rule 10b5-1 plan often suggests a pre-planned liquidity event rather than a reaction to specific negative company news. Such transactions are common across the industry for executives managing their personal portfolios and compensation.

Comparison to Industry Standards

• Insider transactions like this are standard practice for executives and directors in publicly traded companies across various industries, including biotechnology and pharmaceuticals, where stock options are a common form of compensation.
• The use of a Rule 10b5-1 plan aligns with best practices for insiders to avoid accusations of trading on material non-public information, a standard widely adopted by corporate governance frameworks globally.

Stakeholder Impact

• Shareholders: The sale by a director could be perceived as a slight reduction in insider confidence, though mitigated by the 10b5-1 plan. The correction of a previous administrative error demonstrates a commitment to accurate reporting, which is positive for transparency.

Key Dates

Keywords

Liquidia Corp, LQDA, Raman Singh, Insider Transaction, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Director, Beneficial Ownership